Novel Applications of Combination Therapies for Enhanced Productivity and Sustainability

Publication ID: 24-11857541_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Novel Applications of Combination Therapies for Enhanced Productivity and Sustainability,” Published Technical Disclosure No. 24-11857541_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857541_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,541.

Summary of the Inventive Concept

The inventive concept leverages the core technology of combination therapies to revolutionize various industries, including agriculture, food processing, renewable energy, water purification, and infrastructure development, by enhancing productivity, reducing waste, and promoting sustainability.

Background and Problem Solved

The original patent disclosed combination therapies for treating progeroid diseases and conditions, cellular aging, and cardiovascular and bone diseases. However, these therapies have untapped potential for application in other fields. The inventive concept addresses the limitations of the original patent by exploring new use cases, thereby unlocking the full potential of these combination therapies.

Detailed Description of the Inventive Concept

The inventive concept involves the administration of a therapeutically effective amount of a farnesyltransferase inhibitor and an mTOR inhibitor to various systems, including agricultural crops, perishable food products, renewable energy sources, water purification systems, and infrastructure materials. This results in enhanced yields, reduced spoilage, optimized energy production, reduced biofouling, and improved material durability, respectively.

Novelty and Inventive Step

The inventive concept's novelty lies in its unexpected application of combination therapies to entirely new fields, solving problems that were not previously considered. The inventive step is the recognition of the potential for these therapies to have a profound impact on productivity and sustainability across multiple industries.

Alternative Embodiments and Variations

Alternative embodiments may include varying the dosages, formulations, or administration methods of the combination therapies, as well as exploring different types of inhibitors or additional active ingredients. Variations may also involve adapting the inventive concept to address specific challenges or requirements within each target industry.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential across multiple industries, including agriculture, food processing, renewable energy, water purification, and infrastructure development. The market for these applications is vast, with potential customers including farmers, food manufacturers, energy producers, municipalities, and construction companies.

Original Patent Information

Patent NumberUS 11,857,541
TitleCombination therapies for treatment of laminopathies, cellular aging, and atherosclerosis